NEOGENOMICS INC — Director's Dealing 2017

Oct 20, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-10-18

Reporting Person: McKenzie Kathryn B (Principal Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-18	Stock Option (Right to Buy)	$9.07	A	25000	Acquired	2022-10-18	Common Stock (25000)	Direct

Footnotes

F1: On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.